WHO calls for Expressions of Interest in developing Sabin-IPV

Safe and affordable inactivated polio vaccine for low-income countries

The World Health Organization’s Global Polio Eradication Initiative (WHO/POL) is looking for Expressions of Interest from private or public sector vaccine manufacturers in developing countries interested in collaborating with WHO and Intravacc in the development, manufacture and distribution of a safe effective and affordable Sabin Inactivated Polio Vaccine (sIPV), that can be produced securely in developing country settings.

Related


Related News

   23/08/2019
A milestone in an ongoing journey to achieve global polio eradication
   27/06/2019
Research underway on a newer tool to protect children from polio and sustain a polio-free world
   25/06/2019
Reaching underserved populations with immunization in the Niger Delta
   21/06/2019
Everyday people in Pakistan advocating for vaccinations
   10/05/2019
Decades-long polio infrastructure has spill-over benefits across larger public health interventions
   09/05/2019
Momentous global effort enables record-breaking milestone for polio and immunisation